FI100556B - Menetelmä anti-DNA-vasta-aineiden toteamiseksi, diagnostinen menetelmä , reagenssipakkaus ja lääkeaine autoimmuunisairauksia varten - Google Patents

Menetelmä anti-DNA-vasta-aineiden toteamiseksi, diagnostinen menetelmä , reagenssipakkaus ja lääkeaine autoimmuunisairauksia varten

Info

Publication number
FI100556B
FI100556B FI950962A FI950962A FI100556B FI 100556 B FI100556 B FI 100556B FI 950962 A FI950962 A FI 950962A FI 950962 A FI950962 A FI 950962A FI 100556 B FI100556 B FI 100556B
Authority
FI
Finland
Prior art keywords
drug
dna
detection
antibodies
solid phase
Prior art date
Application number
FI950962A
Other languages
English (en)
Swedish (sv)
Other versions
FI950962A (fi
FI950962A0 (fi
Inventor
Eeva-Marjatta Salonen
Original Assignee
Biohit Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oyj filed Critical Biohit Oyj
Publication of FI950962A0 publication Critical patent/FI950962A0/fi
Priority to FI950962A priority Critical patent/FI100556B/fi
Priority to AU47215/96A priority patent/AU720912B2/en
Priority to PCT/FI1996/000117 priority patent/WO1996027131A1/en
Priority to ZA961628A priority patent/ZA961628B/xx
Priority to ES96903036T priority patent/ES2175069T3/es
Priority to DE69621915T priority patent/DE69621915T2/de
Priority to NZ301725A priority patent/NZ301725A/en
Priority to AT96903036T priority patent/ATE219580T1/de
Priority to EP96903036A priority patent/EP0812421B1/en
Publication of FI950962A publication Critical patent/FI950962A/fi
Application granted granted Critical
Publication of FI100556B publication Critical patent/FI100556B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/104—Lupus erythematosus [SLE]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
FI950962A 1995-03-01 1995-03-01 Menetelmä anti-DNA-vasta-aineiden toteamiseksi, diagnostinen menetelmä , reagenssipakkaus ja lääkeaine autoimmuunisairauksia varten FI100556B (fi)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FI950962A FI100556B (fi) 1995-03-01 1995-03-01 Menetelmä anti-DNA-vasta-aineiden toteamiseksi, diagnostinen menetelmä , reagenssipakkaus ja lääkeaine autoimmuunisairauksia varten
ES96903036T ES2175069T3 (es) 1995-03-01 1996-02-29 Deteccion de anticuerpos anti-dna que implica el reconocimiento y la union de secuencias telomericas de dna.
PCT/FI1996/000117 WO1996027131A1 (en) 1995-03-01 1996-02-29 Anti dna antibody detection involving telomeric dna sequence recognition and binding
ZA961628A ZA961628B (en) 1995-03-01 1996-02-29 Diagnostic method test kit drug and therapeutic treatment for autoimmune diseases
AU47215/96A AU720912B2 (en) 1995-03-01 1996-02-29 Anti DNA antibody detection involving telomeric DNA sequence recognition and binding
DE69621915T DE69621915T2 (de) 1995-03-01 1996-02-29 Anti-dns-antikörpernachweis mittels erkennung und bindung telomerischer dns-sequenzen
NZ301725A NZ301725A (en) 1995-03-01 1996-02-29 Anti DNA antibody detection involving telomeric DNA sequence recognition and binding
AT96903036T ATE219580T1 (de) 1995-03-01 1996-02-29 Anti-dns-antikörpernachweis mittels erkennung und bindung telomerischer dns-sequenzen
EP96903036A EP0812421B1 (en) 1995-03-01 1996-02-29 Anti dna antibody detection involving telomeric dna sequence recognition and binding

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI950962A FI100556B (fi) 1995-03-01 1995-03-01 Menetelmä anti-DNA-vasta-aineiden toteamiseksi, diagnostinen menetelmä , reagenssipakkaus ja lääkeaine autoimmuunisairauksia varten

Publications (3)

Publication Number Publication Date
FI950962A0 FI950962A0 (fi) 1995-03-01
FI950962A FI950962A (fi) 1996-09-02
FI100556B true FI100556B (fi) 1997-12-31

Family

ID=8542958

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950962A FI100556B (fi) 1995-03-01 1995-03-01 Menetelmä anti-DNA-vasta-aineiden toteamiseksi, diagnostinen menetelmä , reagenssipakkaus ja lääkeaine autoimmuunisairauksia varten

Country Status (9)

Country Link
EP (1) EP0812421B1 (fi)
AT (1) ATE219580T1 (fi)
AU (1) AU720912B2 (fi)
DE (1) DE69621915T2 (fi)
ES (1) ES2175069T3 (fi)
FI (1) FI100556B (fi)
NZ (1) NZ301725A (fi)
WO (1) WO1996027131A1 (fi)
ZA (1) ZA961628B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030032610A1 (en) 1996-06-03 2003-02-13 Gilchrest Barbara A. Method to inhibit cell growth using oligonucleotides
US7018798B2 (en) * 1997-08-12 2006-03-28 Embedded Concepts, Llc Nucleic acid antigens embedded in thermoplastic
EP1274410A2 (en) * 2000-03-31 2003-01-15 Trustees Of Boston University Use of locally applied dna fragments
WO2005025650A1 (de) * 2003-09-12 2005-03-24 Frank Mattner Apherese-vorrichtung
SI24638A (sl) 2014-02-04 2015-08-31 Univerzitetni kliniÄŤni center Ljubljana Fluorometrična imunska metoda za določanje protiteles proti dvojnoverižni DNA
WO2018190365A1 (ja) * 2017-04-12 2018-10-18 国立大学法人九州大学 神経障害性疼痛マーカー及びその使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE61670T1 (de) * 1985-06-25 1991-03-15 Progen Biotechnik Gmbh Immuntest zum nachweis von antikoerpern gegen dns.
AU1070588A (en) * 1987-01-30 1988-08-04 Diagnostic Products Corporation Measuring anti-dna antibodies
US5489508A (en) * 1992-05-13 1996-02-06 University Of Texas System Board Of Regents Therapy and diagnosis of conditions related to telomere length and/or telomerase activity

Also Published As

Publication number Publication date
AU720912B2 (en) 2000-06-15
EP0812421A1 (en) 1997-12-17
DE69621915D1 (de) 2002-07-25
WO1996027131A1 (en) 1996-09-06
ZA961628B (en) 1996-08-08
NZ301725A (en) 2001-02-23
AU4721596A (en) 1996-09-18
FI950962A (fi) 1996-09-02
ES2175069T3 (es) 2002-11-16
ATE219580T1 (de) 2002-07-15
FI950962A0 (fi) 1995-03-01
DE69621915T2 (de) 2003-01-23
EP0812421B1 (en) 2002-06-19

Similar Documents

Publication Publication Date Title
DE69520149D1 (de) Tie-2 ligande, verfahren zu ihrer herstellung, und ihre anwendungen
HUP9902327A2 (hu) Humán gp39-elleni humanizált antitestek, az antitesteket tartalmazó készítmények és terápiás alkalmazásuk
DE69232309T4 (de) Weitgehend reine rezeptorartige, tgf-beta-1-bindende moleküle und deren verwendungen
DE69841170D1 (de) Menschliche Toll-ähliche Rezeptorproteine, zugehörige Reagenzien und Verfahren
MY136224A (en) Monkey monoclonal antibodies specific to human b7.1 and/or b7.2,primatized forms thereof,pharmaceutical compos itions containing, and use thereof as immunosuppressants
ATE291618T1 (de) Dna codierend für den menschlichen 5-ht 1f rezeptor und ihre verwendung
FR2751986B1 (fr) Gene implique dans le cadasil, methode de diagnostic et application therapeutique
ATE173544T1 (de) Parvovirusrezeptoren und verfahren zur ihrer verwendung
PT973794E (pt) Receptores de netrina
WO2003072598A3 (en) Hsp70-derived peptides an uses thereof in the diagnosis and treatment of autoimmune diseases
CA2344590A1 (en) Treatment of inflammatory disease
DE69233496D1 (de) Dna kodierend für den menschlichen 5-ht 1e-rezeptor und seine verwendungen
ATE245190T1 (de) Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung
FI100556B (fi) Menetelmä anti-DNA-vasta-aineiden toteamiseksi, diagnostinen menetelmä , reagenssipakkaus ja lääkeaine autoimmuunisairauksia varten
DE69720241D1 (de) Ligand (tie ligand-4) vom tie-2 rezeptor und dessen verwendungen
WO1997023611A3 (de) Nukleinsäuresequenzen von genen der high mobility group proteine sowie verwendungen derselben
MXPA02005236A (es) Metodos de tratamiento de lupus con base en la afinidad de anticuerpos y metodos de separacion por exclusion y composiciones para el uso de los mismos.
ATE293994T1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen
WO2003020911A3 (en) Human schizophrenia gene
SE9403953D0 (sv) Sequence-based diagnosis
ATE364180T1 (de) Screeningverfahren mit bnpi und dnpi
HUP0101689A2 (hu) Anti-gp39-ellenanyagok alkalmazása lupusz és ezzel asszociált vesebetegség kezelésére és/vagy visszafejlesztésére
CA2373466A1 (en) Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (eaoh)
WO2000049144A3 (en) Pyk2 binding proteins
WO2002070560A3 (en) Nuclear hormone receptor ligand binding domain

Legal Events

Date Code Title Description
MA Patent expired